# The Antiretroviral Speed Access Program Switch (ASAP-Switch) Study

> **NCT06375304** · PHASE4 · NOT_YET_RECRUITING · sponsor: **McGill University Health Centre/Research Institute of the McGill University Health Centre** · enrollment: 50 (estimated)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** B/F/TAF

## Key facts

- **NCT ID:** NCT06375304
- **Lead sponsor:** McGill University Health Centre/Research Institute of the McGill University Health Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-05-01
- **Primary completion:** 2026-06-01
- **Final completion:** 2027-05-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06375304

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06375304, "The Antiretroviral Speed Access Program Switch (ASAP-Switch) Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06375304. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*